What is the appropriate follow-up after treatment?

S. Sharir, Richard Foster, J. P. Donohue, M. A S Jewett

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Close follow-up after surgery for low volume nonseminomatous testicular cancer is important for early detection of recurrence. However, follow-up involves expense and adds to the burden of treatment. To minimize follow-up, we examined medical literature reports of results in early stage testicular cancer. Additionally, we analyzed our own data for the specific patterns of failure in stages I and II after retroperitoneal lymphadenectomy (RPL) and stage I on surveillance. We conclude that the most rigorous protocols should be reserved for stage I on surveillance and stage II on observation after RPL. Less frequent follow-up is needed for the other treatment options. For all patients, follow-up must be most intense early on, because of the high relapse rate in the first 1 to 2 years. Because there was no correlation noted between the site and timing of relapse in any group, physical examination and marker determination must be performed at every visit. In addition, where the retroperitoneum has been sterilized by RPL, chest x-ray must be performed, but computed tomography (CT) of the abdomen and pelvis is generally unnecessary. For stage I on surveillance, abdominopelvic CT is needed but the value of chest x-ray is questionable.

Original languageEnglish (US)
Pages (from-to)45-53
Number of pages9
JournalSeminars in Urologic Oncology
Volume14
Issue number1
StatePublished - 1996
Externally publishedYes

Fingerprint

Lymph Node Excision
Testicular Neoplasms
Recurrence
Thorax
Tomography
X-Rays
Pelvis
Abdomen
Physical Examination
Therapeutics
Observation

Keywords

  • cancer recurrence
  • early stage
  • follow-up
  • nonseminoma
  • protocol
  • Testicular cancer

ASJC Scopus subject areas

  • Urology

Cite this

Sharir, S., Foster, R., Donohue, J. P., & Jewett, M. A. S. (1996). What is the appropriate follow-up after treatment? Seminars in Urologic Oncology, 14(1), 45-53.

What is the appropriate follow-up after treatment? / Sharir, S.; Foster, Richard; Donohue, J. P.; Jewett, M. A S.

In: Seminars in Urologic Oncology, Vol. 14, No. 1, 1996, p. 45-53.

Research output: Contribution to journalArticle

Sharir, S, Foster, R, Donohue, JP & Jewett, MAS 1996, 'What is the appropriate follow-up after treatment?', Seminars in Urologic Oncology, vol. 14, no. 1, pp. 45-53.
Sharir, S. ; Foster, Richard ; Donohue, J. P. ; Jewett, M. A S. / What is the appropriate follow-up after treatment?. In: Seminars in Urologic Oncology. 1996 ; Vol. 14, No. 1. pp. 45-53.
@article{6f70d0132b654917bc83ef33cf839f19,
title = "What is the appropriate follow-up after treatment?",
abstract = "Close follow-up after surgery for low volume nonseminomatous testicular cancer is important for early detection of recurrence. However, follow-up involves expense and adds to the burden of treatment. To minimize follow-up, we examined medical literature reports of results in early stage testicular cancer. Additionally, we analyzed our own data for the specific patterns of failure in stages I and II after retroperitoneal lymphadenectomy (RPL) and stage I on surveillance. We conclude that the most rigorous protocols should be reserved for stage I on surveillance and stage II on observation after RPL. Less frequent follow-up is needed for the other treatment options. For all patients, follow-up must be most intense early on, because of the high relapse rate in the first 1 to 2 years. Because there was no correlation noted between the site and timing of relapse in any group, physical examination and marker determination must be performed at every visit. In addition, where the retroperitoneum has been sterilized by RPL, chest x-ray must be performed, but computed tomography (CT) of the abdomen and pelvis is generally unnecessary. For stage I on surveillance, abdominopelvic CT is needed but the value of chest x-ray is questionable.",
keywords = "cancer recurrence, early stage, follow-up, nonseminoma, protocol, Testicular cancer",
author = "S. Sharir and Richard Foster and Donohue, {J. P.} and Jewett, {M. A S}",
year = "1996",
language = "English (US)",
volume = "14",
pages = "45--53",
journal = "Urologic Oncology",
issn = "1078-1439",
publisher = "Elsevier Inc.",
number = "1",

}

TY - JOUR

T1 - What is the appropriate follow-up after treatment?

AU - Sharir, S.

AU - Foster, Richard

AU - Donohue, J. P.

AU - Jewett, M. A S

PY - 1996

Y1 - 1996

N2 - Close follow-up after surgery for low volume nonseminomatous testicular cancer is important for early detection of recurrence. However, follow-up involves expense and adds to the burden of treatment. To minimize follow-up, we examined medical literature reports of results in early stage testicular cancer. Additionally, we analyzed our own data for the specific patterns of failure in stages I and II after retroperitoneal lymphadenectomy (RPL) and stage I on surveillance. We conclude that the most rigorous protocols should be reserved for stage I on surveillance and stage II on observation after RPL. Less frequent follow-up is needed for the other treatment options. For all patients, follow-up must be most intense early on, because of the high relapse rate in the first 1 to 2 years. Because there was no correlation noted between the site and timing of relapse in any group, physical examination and marker determination must be performed at every visit. In addition, where the retroperitoneum has been sterilized by RPL, chest x-ray must be performed, but computed tomography (CT) of the abdomen and pelvis is generally unnecessary. For stage I on surveillance, abdominopelvic CT is needed but the value of chest x-ray is questionable.

AB - Close follow-up after surgery for low volume nonseminomatous testicular cancer is important for early detection of recurrence. However, follow-up involves expense and adds to the burden of treatment. To minimize follow-up, we examined medical literature reports of results in early stage testicular cancer. Additionally, we analyzed our own data for the specific patterns of failure in stages I and II after retroperitoneal lymphadenectomy (RPL) and stage I on surveillance. We conclude that the most rigorous protocols should be reserved for stage I on surveillance and stage II on observation after RPL. Less frequent follow-up is needed for the other treatment options. For all patients, follow-up must be most intense early on, because of the high relapse rate in the first 1 to 2 years. Because there was no correlation noted between the site and timing of relapse in any group, physical examination and marker determination must be performed at every visit. In addition, where the retroperitoneum has been sterilized by RPL, chest x-ray must be performed, but computed tomography (CT) of the abdomen and pelvis is generally unnecessary. For stage I on surveillance, abdominopelvic CT is needed but the value of chest x-ray is questionable.

KW - cancer recurrence

KW - early stage

KW - follow-up

KW - nonseminoma

KW - protocol

KW - Testicular cancer

UR - http://www.scopus.com/inward/record.url?scp=0029927935&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029927935&partnerID=8YFLogxK

M3 - Article

C2 - 8833389

AN - SCOPUS:0029927935

VL - 14

SP - 45

EP - 53

JO - Urologic Oncology

JF - Urologic Oncology

SN - 1078-1439

IS - 1

ER -